Title |
An ongoing case-control study to evaluate the NHS breast screening programme
|
---|---|
Published in |
BMC Cancer, December 2013
|
DOI | 10.1186/1471-2407-13-596 |
Pubmed ID | |
Authors |
Nathalie J Massat, Peter D Sasieni, Dharmishta Parmar, Stephen W Duffy |
Abstract |
In England, a national breast screening programme (NHSBSP) has been in place since 1988, and assessment of its impact on breast cancer incidence and mortality is essential to ensure that the programme is indeed doing more good than harm. This article describes large observation studies designed to estimate the effects of the current programme in terms of the benefits on breast cancer incidence and mortality and detrimental effect in terms of overdiagnosis. The case-control design of the cervical screening programme evaluation was highly effective in informing policy on screening intervals and age ranges. We propose innovative selection of cases and controls and gathering of additional variables to address new outcomes of interest and develop new methodologies to control for potential sources of bias. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 2 | 33% |
Unknown | 4 | 67% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 4 | 67% |
Practitioners (doctors, other healthcare professionals) | 1 | 17% |
Scientists | 1 | 17% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 2 | 4% |
Unknown | 45 | 96% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 10 | 21% |
Student > Postgraduate | 6 | 13% |
Student > Master | 5 | 11% |
Student > Ph. D. Student | 5 | 11% |
Researcher | 4 | 9% |
Other | 9 | 19% |
Unknown | 8 | 17% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 21 | 45% |
Nursing and Health Professions | 4 | 9% |
Agricultural and Biological Sciences | 3 | 6% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 4% |
Psychology | 2 | 4% |
Other | 7 | 15% |
Unknown | 8 | 17% |